The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 05, 2023
Filed:
Mar. 18, 2016
Applicant:
Foundation for Biomedical Research and Innovation AT Kobe, Kobe, JP;
Inventors:
Assignee:
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 35/14 (2015.01); A61P 9/10 (2006.01); A61K 35/28 (2015.01); A61K 45/00 (2006.01); A61K 38/48 (2006.01); A61K 38/22 (2006.01); A61K 38/46 (2006.01); A61P 13/12 (2006.01); A61K 38/17 (2006.01); A61K 38/18 (2006.01); C12N 5/00 (2006.01);
U.S. Cl.
CPC ...
A61K 35/14 (2013.01); A61K 35/28 (2013.01); A61K 38/1709 (2013.01); A61K 38/1825 (2013.01); A61K 38/1841 (2013.01); A61K 38/1858 (2013.01); A61K 38/1866 (2013.01); A61K 38/22 (2013.01); A61K 38/46 (2013.01); A61K 38/48 (2013.01); A61K 38/4886 (2013.01); A61K 45/00 (2013.01); A61P 9/10 (2018.01); A61P 13/12 (2018.01); C12N 5/0087 (2013.01); C12Y 304/24024 (2013.01);
Abstract
The present invention provides a sufficiently effective medicine for treatment and/or prevention of ischemic diseases, without performing isolation of therapeutic cells or removal of deleterious cells from blood cells/hemocytes. The blood cells and/or the hemocytes are subjected to the action of a saccharide. The saccharide is a monosaccharide, a disaccharide, a trisaccharide, a polysaccharides, or a copolymer containing a monosaccharide, a disaccharide, or a trisaccharide as a component. The saccharide is a copolymer of sucrose and epichlorohydrin.